Martin Shkreli violating lifetime pharma industry ban, US FTC, states says
MLex Summary: Former pharmaceutical industry executive Martin Shkreli has "flagrantly and repeatedly" violated a 2022 court order banning him from the industry, the US Federal Trade Commission and seven states told...To view the full article, register now.
Already a subscriber? Click here to view full article